Atlas Trials

Stage III Renal Cell Cancer AJCC v7

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage III Renal Cell Cancer AJCC v7

RecordFirmDate
Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed (NCT02761057)National Cancer Institute (NCI)2016-07-25
Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery (NCT02595918)National Cancer Institute (NCI)2016-05-19
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer (NCT01835158)National Cancer Institute (NCI)2013-07-08
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction (NCT01638533)National Cancer Institute (NCI)2012-08-03
Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer (NCT01664182)National Cancer Institute (NCI)2012-08-01
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer (NCT01480154)National Cancer Institute (NCI)2011-11-23
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy (NCT01198158)National Cancer Institute (NCI)2010-09-15
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer (NCT01038778)National Cancer Institute (NCI)2009-10-29
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery (NCT00326898)National Cancer Institute (NCI)2006-04-24
Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer (NCT00121251)National Cancer Institute (NCI)2005-06-03

Track Stage III Renal Cell Cancer AJCC v7 automatically

Every clearance here is in the API, with alerts when new ones post.